PCK2 and non-small cell lung carcinoma: Importantly, PCK2 silencing further increased the cleavages of caspase-9, caspase-3 and PARP (Figures 3G, H), indicating that PCK2-mediated gluconeogenesis is required to prevent the activation of mitochondrial pro-apoptotic signaling in NSCLC cells.